Amgen Got `Awesome Price' for Onyx: Brean's Mack

Aug. 26 (Bloomberg) -- Dr. Celine Gounder, a primary care physician, and Brean Capital's Gene Mack discuss Amgen's purchase of Onyx Pharmaceuticals. They speak with Carol Massar on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

Market Concerns: Perceived or Real?
14:49 - Frederick Lane, managing partner at Lane Generational of Raymond James, talks about fear in the market and the perception of investors. He speaks on "Bloomberg Surveillance." (Source: Bloomberg)
  • A Question of Liquidity in European Banking
  • Grumpy Market Looks at Glass Half-Empty: BofA's Moec
  • Trump and Sanders Shake Up Race to the White House